Longevity Investors, launched back in 2020 as the first industry event series fully focusing on investors, wants to educate investors and connect them to the leading key opinion leaders in the industry. The vision and ambition of Longevity Investors is to bring more capital into the

Longevity medicine is rapidly emerging as a credible, fast-growing discipline in modern healthcare, powered by rigorous science and significant global investment. On October 4–5, 2025, the Asia-Pacific Longevity Society will host the inaugural Asian Pacific Longevity Medicine International Summit (APAC-LMIS) at the SkyCity Marriott Hotel in

Abu Dhabi is set to host the Middle East’s first-of-its-kind conference and exhibition dedicated to longevity science, biotechnology, regenerative medicine, ultra-personalised wellness, and AI-powered healthcare innovation, Revive ME. Taking place on 26 – 27 November 2025 at Beach Rotana, Abu Dhabi, this transformative event will bring

BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the first participant has been dosed in a Phase 1 clinical trial evaluating BGE-102, a structurally novel,

Join us on August 23, 2025, at the MIT Media Lab in Cambridge, MA, for a full-day summit exploring the frontiers of human potential and longevity. The 2025 Human Augmentation Summit is a gathering of creators – from innovative startups and global companies to independent researchers

Immortal Dragons, a purpose-driven longevity fund headquartered in Singapore, today announced its unique approach to investing in radical life extension technologies. With $40 million in assets under management (AUM), Immortal Dragons is poised to redefine how capital fuels scientific breakthroughs in longevity and healthspan. At its

Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter “Chugai”), and Gero PTE. LTD. (hereafter “Gero”), a Singapore-based biotechnology company, announced today that they have entered into a joint research and license agreement to develop novel therapies for age-related diseases. In this collaboration, Chugai will create novel antibody drug candidates using

We are thrilled to announce the second edition of the International Longevity Summit (www.TransVisionMadrid.com) in beautiful Madrid after the major success in 2024. Organized by the Illustrious College of Medical Doctors of Madrid (ICOMEM) and the International Longevity Alliance (ILA), this year we expect over 500

As China’s population ages rapidly, the development of the longevity industry has been prioritized to the level of national strategy since 2024. To drive its growth, government policies support a broad spectrum of longevity innovations, ranging from preventive wellness to nutritional supplements. Free Trade Zones such

Viva.city and BerlinHouse are opening Viva Frontier Tower, a 6-week popup village in the newly purchased 16-floor Frontier Tower in downtown San Francisco. From June 20 to August 4, this space will bring together people building the future in AI, Crypto, and Longevity. One Tower. Three

Scientists have developed a new open source transcriptomic aging clock and published their work as a pre-print [1]. The newly identified rejuvenating drugs and gene perturbations could be applied in regenerative medicine and longevity therapies, and the aging perturbations could find use for anti-cancer therapies. Age-shift

Circulate Health, the company dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, today announces the publication of a single blind, human clinical trial in Aging Cell. This groundbreaking study, led by researchers from Circulate and the Buck Institute

The Longevity Science Foundation (LSF), a nonprofit organization dedicated to funding research aimed at extending the healthy human lifespan, is proud to announce a grant award to the University of Copenhagen’s Center for Healthy Aging within the Department of Cellular and Molecular Medicine, for the study

London, UK – May 13, 2025 – Industry analysts at Longevity.Technology today published the 2024 Annual Longevity Investment Report – a full-year report on the state of investment in the longevity sector – with total financing reaching USD $8.49 billion across 331 deals. The report analyses